{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:14Z","timestamp":1786119074355,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Sup 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1111\/j.1524-4725.2008.01047.x","type":"journal-article","created":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T16:01:08Z","timestamp":1233590468000},"page":"350-359","source":"Crossref","is-referenced-by-count":24,"title":["Retreatment with Injectable Poly-l-Lactic Acid for HIV-Associated Facial Lipoatrophy"],"prefix":"10.1097","volume":"35","author":[{"given":"Douglas R.","family":"Mest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail M.","family":"Humble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","article-title":"Assessment of the safety and efficacy of poly-l-lactic acid for the treatment of HIV-associated facial lipoatrophy.","volume":"52","author":"Burgess","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R2-8-20210206","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1468-1293.2006.00342.x","article-title":"Long-term safety and efficacy of poly-l-lactic acid in the treatment of HIV-related facial lipoatrophy.","volume":"7","author":"Moyle","year":"2006","journal-title":"HIV Med"},{"key":"R3-8-20210206","first-page":"546","article-title":"Psychosocial impact of the lipodystrophy syndrome in HIV infection.","volume":"10","author":"Collins","year":"2000","journal-title":"AIDS Read"},{"key":"R4-8-20210206","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00042560-200111010-00005","article-title":"The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort.","volume":"28","author":"Carrieri","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-8-20210206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/sti.79.2.137","article-title":"A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals.","volume":"79","author":"Power","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R6-8-20210206","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00002018-200124030-00001","article-title":"Lipodystrophy syndrome in patients with HIV infection: quality of life issues.","volume":"24","author":"Martinez","year":"2001","journal-title":"Drug Saf"},{"key":"R7-8-20210206","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy.","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"key":"R8-8-20210206","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2310\/6350.2005.31236","article-title":"Facial volumetric correction with injectable poly-l-lactic acid.","volume":"31","author":"Vleggaar","year":"2005","journal-title":"Dermatol Surg"},{"key":"R9-8-20210206","first-page":"385","article-title":"Poly-l-lactic acid: a temporary filler for soft tissue augmentation.","volume":"3","author":"Woerle","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"R10-8-20210206","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection.","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med"},{"key":"R11-8-20210206","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"R12-8-20210206","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archderm.142.3.329","article-title":"Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy.","volume":"142","author":"Cattelan","year":"2006","journal-title":"Arch Dermatol"},{"key":"R13-8-20210206","first-page":"1336","article-title":"Safety and efficacy of poly-l-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience.","volume":"32","author":"Mest","year":"2006","journal-title":"Dermatol Surg"},{"issue":"suppl 1","key":"R15-8-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01518.x","article-title":"Poly-l-lactic acid: consultation on the injection techniques.","volume":"20","author":"Vleggaar","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R16-8-20210206","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.qai.0000152834.02912.98","article-title":"Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients.","volume":"38","author":"Lafaurie","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-8-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00266-003-3022-1","article-title":"Human histology and persistence of various injectable filler substances for soft tissue augmentation.","volume":"27","author":"Lemperle","year":"2003","journal-title":"Aesthet Plast Surg"},{"key":"R18-8-20210206","first-page":"979","article-title":"HIV-associated facial lipoatrophy.","volume":"28","author":"James","year":"2002","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1111\/j.1524-4725.2008.01047.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:42:45Z","timestamp":1786038165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-200902001-00008"}},"subtitle":["24-Month Extension of the Blue Pacific Study"],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":17,"journal-issue":{"issue":"Sup 1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2008.01047.x","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}